Por favor, use este identificador para citar o enlazar este ítem: http://repositorio.pediatria.gob.mx:8180/handle/20.500.12103/2180
Título : Clinical and mutational features of X-linked agammaglobulinemia in Mexico
Creador: García García E
Nivel de acceso: Open access
Palabras clave : Agammaglobulinemia - complicaciones
Agammaglobulinemia - diagnóstico
Agammaglobulinemia - genética
Agammaglobulinemia - patología
Artritis - complicaciones
Enfermedades Genéticas Ligadas al Cromosoma X - complicaciones
Enfermedades Genéticas Ligadas al Cromosoma X - diagnóstico
Enfermedades Genéticas Ligadas al Cromosoma X - genética
Enfermedades Genéticas Ligadas al Cromosoma X -patología
Humanos
Inmunoglobulina A - sangre
Inmunoglobulina A - genética
Inmunoglobulina G sangre
Inmunoglobulina G - genética
Inmunoglobulina M, sangre
Inmunoglobulina M - genética
México
Mutación Missense - genética
Agammaglobulinemia - complications
Agammaglobulinemia - diagnosis
Agammaglobulinemia - genetics
Agammaglobulinemia - pathology
Arthritis - complications
Genetic Diseases, X-Linked -complications
Genetic Diseases, X-Linked - diagnosis
Genetic Diseases, X-Linked - genetics
Genetic Diseases, X-Linked - pathology
Humans
Immunoglobulin A - blood
Immunoglobulin A - genetics
Immunoglobulin G - blood
Immunoglobulin G - genetics
Immunoglobulin M - blood
Immunoglobulin M - genetics
Mexico
Mutation, Missense - genetics
BTK; Mutaciones sin sentido; Empalme de sitio; Agammaglobulinemia X-ligado
Btk; Missense mutations; Splice site; X-linked agammaglobulinemia
Descripción : X-linked agammaglobulinemia (XLA) is caused by BTK mutations, patients typically show <. 2% of peripheral B cells and reduced levels of all immunoglobulins; they suffer from recurrent infections of bacterial origin; however, viral infections, autoimmune-like diseases, and an increased risk of developing gastric cancer are also reported. In this work, we report the BTK mutations and clinical features of 12 patients diagnosed with XLA. Furthermore, a clinical revision is also presented for an additional cohort of previously reported patients with XLA. Four novel mutations were identified, one of these located in the previously reported mutation refractory SH3 domain. Clinical data support previous reports accounting for frequent respiratory, gastrointestinal tract infections and other symptoms such as the occurrence of reactive arthritis in 19.2% of the patients. An equal proportion of patients developed septic arthritis; missense mutations and mutations in SH1, SH2 and PH domains predominated in patients who developed arthritis. © 2016 Elsevier Inc.
Colaborador(es) u otros Autores: Staines-Boone At
Vargas-Hernández A
González-Serrano Me
Carrillo-Tapia E
Mogica-Martínez D
Berrón-Ruíz L
Segura-Mendez Nh
Espinosa-Rosales Fj
Yamazaki-Nakashimada Ma
Santos-Argumedo L
López-Herrera G
Fecha de publicación : 2016
Tipo de publicación: Artículo
Formato: pdf
Identificador del Recurso : 10.1016/j.clim.2016.02.010
Fuente: Clinical Immunology 165():38 - 44
URI : http://repositorio.pediatria.gob.mx:8180/handle/20.500.12103/2180
Idioma: eng
Aparece en las colecciones: Artículos

Ficheros en este ítem:
No hay ficheros asociados a este ítem.


Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.